Wonder drug for hepatitis C has $90,000 price tag
WASHINGTON — Your money or your life?
Sovaldi, a new pill for hepatitis C, cures the liver-wasting disease in 9 of 10 patients, but treatment can cost more than $90,000.
Leading medical societies recommend the drug as a first-line treatment, and patients are clamoring for it. But insurance companies and state Medicaid programs are balking at the price. In Oregon, officials propose to limit how many low-income patients can get Sovaldi.
Yet if Sovaldi didn't exist, insurers would still be paying in the mid-to-high five figures to treat the most common kind of hepatitis C, a new pricing survey indicates. Some of the older alternatives involve more side effects, and are less likely to provide cures.
So what's a fair price?
The cost of this breakthrough drug is highlighting cracks in the health care system at a time of heightened budget concerns. The Obama administration has a huge political stake in controlling treatment costs, but its critics may cry rationing.
“People are going to want to try to dodge this hot potato,” says economist Douglas Holtz-Eakin.
For insurers, there's a frustrating twist: For each middle-aged person they pay to cure with Sovaldi, any financial benefits from preventing liver failure are likely to accrue to Medicare, not to them.
More than 3 million Americans carry the hepatitis C virus, and many don't realize it. It's a public health concern since the disease can be transmitted by contact with infected blood, and sometimes through sexual activity. Health officials advise all baby boomers to get tested.
Show commenting policy
TribLive commenting policy
- Suspect in killings of wealthy D.C. family arrested
- Dogs split from the wolf pack earlier than thought, DNA analysis suggests
- Senators push for full funding for Amtrak
- Suspect in killings of wealthy DC family arrested
- Experts cited concerns with medical scope infections in ‘09
- 6 Baltimore officers indicted in Gray’s death
- Obama trade bill advances in Senate
- Ex-Va. lawmaker plans to wed teen in sex scandal
- NSA extension up to senators
- Santa Barbara oil spill rallies ‘green’ crusaders
- Texan bags black rhino in benefit hunt